e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vitro
effects of vibrating mesh nebulization and radiopharmaceuticals on interferon gamma
K. Harris, L. Morra, A. Shah, G. Smaldone (Stony Brook, NY, United States Of America)
Source:
Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session:
Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Session type:
Thematic Poster Session
Number:
782
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Harris, L. Morra, A. Shah, G. Smaldone (Stony Brook, NY, United States Of America).
In vitro
effects of vibrating mesh nebulization and radiopharmaceuticals on interferon gamma. Eur Respir J 2007; 30: Suppl. 51, 782
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Delivery and efficacy of synthetic oligonucleotide vectors to an ARDS model by vibrating mesh nebulisation
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Aerosol characterization of alpha-1 antitrypsin after nebulization with eFlow®, a novel vibrating membrane nebulizer
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006
A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008
In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002
Visualising biodistribution and biokinetics of inhaled biologicals: application of light sheet imaging technology
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
Comparative lung bioavailability of fluticasone/salmeterol via breath actuated vortex spacer and conventional plastic spacers
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010
A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable
in vitro
performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014
The
in vitro
fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005
Inhaled corticosteroid fine particle dose from valved holding chambers
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010
Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
In vitro
testing of inhalation devices with face masks
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001
A portable device capable to deliver to the airways filtered air with a submicrometric particle removal efficiency up to 90%
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
Validation of monodisperse corticosteroid aerosols for in-vivo delivery
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept